RemeGen Co Ltd
HKEX:9995
RemeGen Co Ltd
Operating Income
RemeGen Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
RemeGen Co Ltd
HKEX:9995
|
Operating Income
-¥1.5B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥8.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥8.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
34%
|
CAGR 10-Years
53%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
See Also
What is RemeGen Co Ltd's Operating Income?
Operating Income
-1.5B
CNY
Based on the financial report for Dec 31, 2023, RemeGen Co Ltd's Operating Income amounts to -1.5B CNY.
What is RemeGen Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-46%
Over the last year, the Operating Income growth was -41%. The average annual Operating Income growth rates for RemeGen Co Ltd have been -31% over the past three years , -46% over the past five years .